All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
MONTE ROSA THERAPEUTICS, INC. Last Reported: 5/31/2024 Stock Symbol: GLUE

Business Address

321 HARRISON AVENUE
SUITE 900
BOSTON , MA US 02118

Mailing Address

321 HARRISON AVENUE
SUITE 900
BOSTON , MA US 02118
Phone Number: 617-949-2643 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $99,752,000.00 $128,101,000.00 $59,055,000.00 $47,027,000.00 $51,847,000.00 $54,912,000.00 $112,394,000.00 $103,664,000.00 $346,071,000.00 $367,000,000.00 $357,100,000.00 -- $41,699,000.00 $12,706,000.00 -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $5,543,000.00 $3,294,000.00 $4,140,000.00 $3,884,000.00 $5,692,000.00 $4,444,000.00 $4,569,000.00 $2,900,000.00 $2,595,000.00 $3,485,000.00 $1,229,000.00 -- $1,892,000.00 -- -- --
Total Current Assets $199,036,000.00 $236,212,000.00 $182,911,000.00 $208,104,000.00 $240,556,000.00 $275,886,000.00 $295,235,000.00 $297,045,000.00 $348,666,000.00 $370,519,000.00 $358,289,000.00 -- $43,591,000.00 -- -- --
Property Plant and Equipement $34,036,000.00 $33,803,000.00 $34,992,000.00 $35,335,000.00 $33,266,000.00 $27,075,000.00 $19,384,000.00 $15,205,000.00 $12,325,000.00 $11,801,000.00 $8,923,000.00 -- $4,623,000.00 -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $389,000.00 $352,000.00 $270,000.00 $291,000.00 $351,000.00 $278,000.00 $148,000.00 $384,000.00 -- -- -- -- -- -- -- --
Total Assets $266,746,000.00 $303,755,000.00 $252,103,000.00 $278,616,000.00 $309,028,000.00 $342,389,000.00 $357,603,000.00 $365,056,000.00 $366,329,000.00 $384,049,000.00 $368,941,000.00 -- $49,378,000.00 -- -- --
Accounts Payable $6,828,000.00 $11,152,000.00 $5,500,000.00 $5,308,000.00 $7,382,000.00 $7,862,000.00 $9,753,000.00 $4,294,000.00 $6,558,000.00 $3,530,000.00 $7,463,000.00 -- $7,066,000.00 -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $114,227,000.00 $124,505,000.00 $67,579,000.00 $64,962,000.00 $65,302,000.00 $70,976,000.00 $66,511,000.00 $63,006,000.00 $18,814,000.00 $14,744,000.00 $12,263,000.00 -- $30,342,000.00 -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $553,063,000.00 $547,857,000.00 $518,610,000.00 $513,041,000.00 $507,688,000.00 $503,696,000.00 $493,443,000.00 $476,939,000.00 $471,566,000.00 $469,845,000.00 $436,847,000.00 -- $404,000.00 -- -- --
Accumulated Other Comprehensive Loss $-2,693,000.00 $-2,724,000.00 $-1,455,000.00 $-1,640,000.00 $-1,393,000.00 $-1,752,000.00 $-2,602,000.00 $-2,458,000.00 $-2,021,000.00 $-1,950,000.00 $-1,415,000.00 -- $-1,056,000.00 -- -- --
Accumulated Deficit $-397,900,000.00 $-365,888,000.00 $-332,600,000.00 $-297,800,000.00 $-262,574,000.00 $-230,500,000.00 $-199,754,000.00 $-172,436,000.00 $-122,035,000.00 $-98,595,000.00 $-78,800,000.00 -- $-48,077,000.00 -- -- --
Total Stockholders' Equity $152,519,000.00 $179,250,000.00 $184,524,000.00 $213,654,000.00 $243,726,000.00 $271,413,000.00 $291,092,000.00 $302,050,000.00 $347,515,000.00 $369,305,000.00 $356,678,000.00 $-60,616,000.00 $-48,728,000.00 $-21,706,000.00 $-16,439,000.00 $-12,148,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $266,746,000.00 $303,755,000.00 $252,103,000.00 $278,616,000.00 $309,028,000.00 $342,389,000.00 $357,603,000.00 $365,056,000.00 $366,329,000.00 $384,049,000.00 $368,941,000.00 -- $49,378,000.00 -- -- --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $27,026,000.00 $111,272,000.00 $84,137,000.00 $29,076,000.00 $26,755,000.00 $85,061,000.00 $21,342,000.00 $20,936,000.00 $57,155,000.00 $15,115,000.00 $23,910,000.00 -- -- $8,670,000.00 -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $36,011,000.00 $143,311,000.00 $36,968,000.00 $71,480,000.00 $34,259,000.00 $112,384,000.00 $79,895,000.00 $51,533,000.00 $72,882,000.00 $49,495,000.00 $29,627,000.00 -- -- $9,689,000.00 -- --
Loss from Operations $-34,947,000.00 $-143,311,000.00 $-36,968,000.00 $-37,221,000.00 $-34,259,000.00 $-112,384,000.00 $-79,895,000.00 $-27,231,000.00 $-72,882,000.00 $-49,495,000.00 $-29,627,000.00 -- -- $-9,689,000.00 -- --
Loss Before Income Taxes $-31,885,000.00 $-135,014,000.00 $-101,740,000.00 $-67,026,000.00 -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 60,156,187 51,396,961 49,533,143 49,431,922 49,347,473 47,227,370 46,666,000 46,632,279 -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 60,156,187 51,396,961 49,533,143 49,431,922 49,347,473 47,227,370 46,666,000 46,632,279 -- -- -- -- -- -- -- --
Common Stock Shares Authorized 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 -- 97,500,000 -- -- --
Common Stock Shares Outstanding 50,200,304 50,140,233 50,065,680 49,592,479 49,360,984 49,323,531 48,372,781 46,684,658 46,535,966 46,483,918 44,603,731 -- 1,685,534 -- -- --
Common Stock Value $5,000.00 $5,000.00 $5,000.00 $5,000.00 $5,000.00 $5,000.00 $5,000.00 $5,000.00 $5,000.00 $5,000.00 $4,000.00 -- $1,000.00 -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com